Reduction of Sweetened Beverages and Intrahepatic Fat (REDUCS)

June 3, 2014 updated by: Luc Tappy, MD, University of Lausanne

Effects of a Reduction of Sweetened Beverages Consumption in Overweight High Consumers on Cardiometabolic Risk Factors

The study will enroll 68 overweight male and female subjects with a high (> 2 3dl-can soda/day) consumption of sweetened beverage per day. After a run-in period of 4 weeks, subjects will be randomized to either a 12-week intervention arm in which sweetened beverages will be replaced by artificially sweetened, calorie-free beverages, or to a control arm. The following measurements will be performed at the end of the run-in period and at the end of the intervention period

  • intrahepatic fat concentration
  • visceral fat volume
  • changes in day-long metabolic profile from baseline(plasma glucose, insulin, and triglyceride concentrations)
  • changes in food intake and daily energy, carbohydrate and sugars intake from baseline

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

29

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • VD
      • Lausanne, VD, Switzerland, CH-1011
        • Clinical Research Center, CHUV

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • gender male or female
  • body mass index (BMI) > 27 kg/m2 consumption of > 2 3dl-can regular soda/day
  • low to moderate physical activity (< 60 min walking/day; < 3 exercise session/week

Exclusion Criteria:

  • diabetes mellitus
  • liver, kidney or heart disease
  • any current drug treatment
  • contra-indications to MR examination (pacemaker, foreign bodies,etc)
  • pregnancy or planned pregnancy
  • active weight gain or weight loss (weight change > 4 kg in the past 12 months)
  • consumption of drugs or illicit substances
  • consumption of more than 10g alcohol/day
  • vegetarians or subjects on special diets

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: artificially sweetened beverages
subjects will be required to consume only artificially-sweetened sodas, water, tea or coffee
subjects will be allowed unlimited consumption of calorie-free, artificially-sweetened sodas, water, tea or coffee
NO_INTERVENTION: regular sodas
subjects will continue their usual consumption of sweetened sodas

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
changes in intrahepatic fat concentration
Time Frame: at the end of run-in and after 12 weeks intervention/control
intrahepatic fat content measured by 1H-MRS
at the end of run-in and after 12 weeks intervention/control

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
changes in visceral fat volume
Time Frame: at the end of run-in and after 12 weeks of intervention/control
Visceral fat volume measured by MRI
at the end of run-in and after 12 weeks of intervention/control
changes in day-long metabolic profile
Time Frame: at the end of run-in and after 12 weeks of intervention/control
Plasma glucose, insulin, non-esterified fatty acids, and triglycerides will be measured at 2-hourly intervals between 7:00 am and 5:00 pm. Participants will be fed standardized meals and either sweetened or artificially-sweetened beverages according to randomization
at the end of run-in and after 12 weeks of intervention/control
changes in food intake from baseline
Time Frame: at the end of the run-in period and after 6, and 12 weeks of intervention/control
Total energy intake, total carbohydrate intake, and total sugars intake will be evaluated by 3-day food record
at the end of the run-in period and after 6, and 12 weeks of intervention/control

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Luc Tappy, MD, Department of Physiology, University of Lausanne

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2011

Primary Completion (ACTUAL)

April 1, 2014

Study Completion (ACTUAL)

April 1, 2014

Study Registration Dates

First Submitted

July 12, 2011

First Submitted That Met QC Criteria

July 13, 2011

First Posted (ESTIMATE)

July 14, 2011

Study Record Updates

Last Update Posted (ESTIMATE)

June 4, 2014

Last Update Submitted That Met QC Criteria

June 3, 2014

Last Verified

June 1, 2014

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on artificially sweetened sodas

Subscribe